Intravenous nicotine self-administration and cue-induced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training.
about
Genetic matters: thirty years of progress using mouse models in nicotinic research.Negative affective states and cognitive impairments in nicotine dependenceNicotine Acutely Enhances Reinforcement from Non-Drug Rewards in HumansPossible reinforcement enhancing effects of bupropion during initial smoking abstinence.Mouse models for studying genetic influences on factors determining smoking cessation success in humans.Integrated miRNA-mRNA analysis in the habenula nuclei of mice intravenously self-administering nicotineStimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet.Mechanisms of epigenetic memory and addiction.Targeted deletion of the mouse α2 nicotinic acetylcholine receptor subunit gene (Chrna2) potentiates nicotine-modulated behaviors.Genetic factors control nicotine self-administration in isogenic adolescent rat strains.Nicotine and ethanol co-use in Long-Evans rats: Stimulatory effects of perinatal exposure to a fat-rich diet.Nicotine-taking and nicotine-seeking in C57Bl/6J mice without prior operant training or food restrictionBehavioral mechanisms underlying nicotine reinforcement.Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in ratsCocaine-related behaviors in mice with deficient gliotransmission.Impact of tobacco regulation on animal research: new perspectives and opportunitiesCC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation.Potential therapeutic uses of mecamylamine and its stereoisomers.Transient compensatory smoking in response to placebo cigarettesDonepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats.Rats are the smart choice: Rationale for a renewed focus on rats in behavioral genetics.Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.Nicotine aversion: Neurobiological mechanisms and relevance to tobacco dependence vulnerability.Utility of genetically modified mice for understanding the neurobiology of substance use disorders.GLP-1 acts on habenular avoidance circuits to control nicotine intake.Intravenous self-administration of alcohol in rats-problems with translation to humans.Altered Baseline and Nicotine-Mediated Behavioral and Cholinergic Profiles in ChAT-Cre Mouse Lines.Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice.Role of α4- and α6-containing nicotinic receptors in the acquisition and maintenance of nicotine self-administration.A computerized exposure system for animal models to optimize nicotine delivery into the brain through inhalation of electronic cigarette vapors or cigarette smoke.Response dynamics of midbrain dopamine neurons and serotonin neurons to heroin, nicotine, cocaine, and MDMA
P2860
Q26853457-2B3222DE-F007-4F33-AA38-72AA0A8B0064Q30371220-DD4C6B56-1068-4682-A796-81BF62FEE333Q30401992-CB52E8DF-817E-4E3E-8C87-156B019B4962Q30422830-31DB3193-7ED0-4C32-A7D8-D2A1841E6190Q30432964-61ACC014-546E-4C16-A1AA-11D2049DA50AQ30660632-65EA942A-641D-457C-84DD-48416E5BD935Q33552906-173BF0B9-A3A7-4933-AEC8-6038710BE20DQ34323788-7482B5D1-346E-4036-B05B-7378E385EA66Q34342415-44624419-23CE-455A-99BD-8F05F10C4932Q34399720-86FB60F6-E367-499E-81E9-A2B8BD1F2487Q35748436-9CD03EA6-4014-44E4-B518-17E7BAF55389Q35846351-A0EBDF54-1733-42F1-BF87-D921A8E14982Q35954791-D865F9CB-BF5C-4179-B125-4E95048FAE1DQ36174102-1FA0A245-D92A-440D-9314-95E7B3758FD7Q36609625-C50C2B8F-6347-4BAF-B272-4F7CA3C041D3Q36727831-9540E503-F804-4F94-81FC-7C5460981370Q36781037-30A76E96-6D27-4EAC-A82C-5170CE931597Q36949979-8CD838C5-32AC-4139-AFEF-3E08DDEE5609Q37242430-CCA0C455-E8D3-4A6F-8CB1-404FA3876C01Q37282357-2DFAA2C1-C5E4-4263-9AFE-55BE7A1942A1Q37296970-B1480017-D0E3-4662-ADC8-859FAA06401AQ37351302-D31C574E-2A05-4DA3-B04A-34E85ABCCFFAQ37381294-58AD31B4-2CE2-48D3-87A0-8BBCC52DC200Q37687946-7BED4EDD-0006-4C6F-BEFE-996FBA7D149AQ38432197-E330FB75-C3D1-44B0-80D0-5E6C684B150BQ38915250-BB6FEE11-4C42-4054-91FF-849FF7425354Q47548840-2065E1E9-438B-4DE7-B135-3C90380E3636Q47603823-149FC1DE-295A-46C9-B1B9-531CB84EAB6CQ50647796-C35EF88E-4E7C-4C01-815B-0D26E0A58F37Q55501911-C897001C-88A1-4847-AB87-7A4F0BD563BAQ58700126-57FC02BC-6BE9-4C82-9004-CEE37718825E
P2860
Intravenous nicotine self-administration and cue-induced reinstatement in mice: effects of nicotine dose, rate of drug infusion and prior instrumental training.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Intravenous nicotine self-admi ...... d prior instrumental training.
@ast
Intravenous nicotine self-admi ...... d prior instrumental training.
@en
type
label
Intravenous nicotine self-admi ...... d prior instrumental training.
@ast
Intravenous nicotine self-admi ...... d prior instrumental training.
@en
prefLabel
Intravenous nicotine self-admi ...... d prior instrumental training.
@ast
Intravenous nicotine self-admi ...... d prior instrumental training.
@en
P2860
P1433
P1476
Intravenous nicotine self-admi ...... d prior instrumental training.
@en
P2093
Christie D Fowler
Paul J Kenny
P2860
P304
P356
10.1016/J.NEUROPHARM.2011.05.012
P577
2011-05-25T00:00:00Z